Table 1.
Baseline characteristics
| Characteristic | Group 1: Recipients Age ≥60 yr | Group 2: Recipients Age 40–59 yr | ||
|---|---|---|---|---|
| SCD | ECD | SCD | ECD | |
| Patient age (yr) | 66 | 67 | 50a | 53a |
| Donor age (yr) | 41b | 64b | 37a | 61a |
| Waiting time (yr) | 1.70b | 1.72b | 1.70a | 1.95a |
| Preemptive transplantc | 9 | 8 | 16 | 12 |
| Diabetes | 29 | 33 | 31 | 30 |
| Hypertension | 96 | 97 | 98 | 96 |
| Coronary artery disease | 42 | 43 | 28 | 21 |
| Cerebrovascular accident | 1 | 0 | 0 | 0 |
| Preservation time (h) | 21.31 | 20.86 | 21.36 | 21.92 |
| Female recipients | 39 | 45 | 38 | 45 |
| Female donors | 39 | 51 | 37 | 53a |
| Induction | ||||
| alemtuzumab | 48 | 51 | 51 | 50 |
| basiliximab | 46 | 45 | 43 | 37 |
| antithymocyte globulin | 6 | 4 | 7 | 12 |
| sirolimus | 8b | 19b | 12 | 20 |
Values are percentage of patients unless otherwise noted. In the induction category, 10% of the patients in group 2 did not have data. Also in group 2, there was a significant difference in induction between the 3 groups when compared as a whole by Fisher exact test. SCD, standard-criteria donor; ECD, extended-criteria donor.
a
Differences between group 2 values were significant (P<0.05).
b
Differences between group 1 values were significant (P<0.05).
c
Patients underwent transplantation before dialysis.